MedPlus Health Services Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
May 25, 2023 at 12:00 pm
Share
MedPlus Health Services Limited reported earnings results for the fourth quarter and full year ended March 31, 2023. For the fourth quarter, the company reported sales was INR 12,529.82 million compared to INR 9,659.07 million a year ago. Revenue was INR 12,666.76 million compared to INR 9,789.55 million a year ago. Net income was INR 265.82 million compared to INR 117.26 million a year ago. Basic earnings per share from continuing operations was INR 2.24 compared to INR 0.99 a year ago. Diluted earnings per share from continuing operations was INR 2.24 compared to INR 0.98 a year ago.
For the full year, sales was INR 45,575.76 million compared to INR 37,792.79 million a year ago. Revenue was INR 46,036.54 million compared to INR 38,106.42 million a year ago. Net income was INR 497.63 million compared to INR 958.02 million a year ago. Basic earnings per share from continuing operations was INR 4.17 compared to INR 8.55 a year ago. Diluted earnings per share from continuing operations was INR 4.17 compared to INR 8.52 a year ago.
MedPlus Health Services Limited is an India-based omni channel retail pharmacy. The Company is primarily engaged in retail trading of medicines and general items, wholesale cash and carry and pathological laboratory testing services, wholesale trading and manufacturing of pharmaceutical products, fast-moving consumer goods and beauty products. It operates through two segments: Retail and Diagnostics. The Retail segment is engaged in retail trading of medicines and general items. The Diagnostics segment is engaged in the diagnostic services. The Company operates approximately 3,882 stores in 552 cities distributed across Tamil Nadu, Andhra Pradesh, Telangana, Karnataka, Odisha, West Bengal, and Maharashtra. Its omni-channel platform enables the Company to service its customers through its stores, as well as its online channels. Its subsidiaries include Optival Health Solutions Private Limited, MHS Pharmaceuticals Private Limited, Kalyani Meditimes Private Limited, and others.